(Q59119594)

English

Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial

scientific article published on 26 July 2012

Statements

Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit